Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Polyploidy, aneuploidy and the evolution of cancer.

Merlo LM, Wang LS, Pepper JW, Rabinovitch PS, Maley CC.

Adv Exp Med Biol. 2010;676:1-13. Review.

PMID:
20687466
2.

Early events during neoplastic progression in Barrett's esophagus.

Reid BJ.

Cancer Biomark. 2010;9(1-6):307-24. doi: 10.3233/CBM-2011-0162. Review.

3.

Barrett's esophagus: a model of human neoplastic progression.

Neshat K, Sanchez CA, Galipeau PC, Cowan DS, Ramel S, Levine DS, Reid BJ.

Cold Spring Harb Symp Quant Biol. 1994;59:577-83. Review. No abstract available.

PMID:
7587115
5.

Barrett's oesophagus: from metaplasia to dysplasia and cancer.

Fléjou JF.

Gut. 2005 Mar;54 Suppl 1:i6-12. Review.

6.

Biomarkers in Barrett's esophagus.

Reid BJ, Blount PL, Rabinovitch PS.

Gastrointest Endosc Clin N Am. 2003 Apr;13(2):369-97. Review.

PMID:
12916666
7.

Barrett's esophagus: a molecular perspective.

Spechler SJ.

Curr Gastroenterol Rep. 2005 Jun;7(3):177-81. Review.

PMID:
15913475
8.

Barrett's esophagus: model of neoplastic progression.

Ramel S.

World J Surg. 2003 Sep;27(9):1009-13. Epub 2003 Aug 18. Review.

PMID:
12917763
9.

Risk factors for neoplastic progression in Barrett's esophagus.

Wiseman EF, Ang YS.

World J Gastroenterol. 2011 Aug 28;17(32):3672-83. doi: 10.3748/wjg.v17.i32.3672. Review.

10.

Barrett's oesophagus--a pathologist's view.

Fléjou JF, Svrcek M.

Histopathology. 2007 Jan;50(1):3-14. Review.

PMID:
17204017
11.

Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.

Odze RD, Lauwers GY.

Endoscopy. 2008 Dec;40(12):1008-15. doi: 10.1055/s-0028-1103416. Epub 2008 Dec 8. Review.

PMID:
19065484
12.

Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.

Beilstein M, Silberg D.

Gastroenterol Clin North Am. 2002 Jun;31(2):461-79, ix. Review.

PMID:
12134613
13.

[Barrett's esophageal cancer].

Makuuchi H.

Gan To Kagaku Ryoho. 2002 Feb;29(2):161-8. Review. Japanese.

PMID:
11865619
14.

Neoplastic risk assessment in Barrett's esophagus: How far have we come?

Noffsinger A.

Hum Pathol. 2003 Oct;34(10):965-7. Review. No abstract available.

PMID:
14608528
15.

Molecular mechanisms of Barrett's esophagus.

Chen H, Fang Y, Tevebaugh W, Orlando RC, Shaheen NJ, Chen X.

Dig Dis Sci. 2011 Dec;56(12):3405-20. doi: 10.1007/s10620-011-1885-6. Epub 2011 Oct 8. Review.

16.

Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins.

Nguyen HG, Ravid K.

J Cell Physiol. 2006 Jul;208(1):12-22. Review.

PMID:
16331679
17.

[Barrett's esophagus: the biological reality of a premaligmant columnar metaplasia].

Sánchez-Fayos P, Martín MJ, González A, Bosch O, Polo B, Arocena C, Porres JC.

Gastroenterol Hepatol. 2002 Apr;25(4):254-66. Review. Spanish. No abstract available.

PMID:
11975875
18.

Strategies for molecular intervention in esophageal cancers and their precursor lesions.

Schrump DS, Nguyen DM.

Dis Esophagus. 1999;12(3):181-5. Review.

PMID:
10631909

Supplemental Content

Support Center